Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Regulatory News

Date Source Headline
10th Nov 2016 7:04 am RNS Year-To-Date and Q3 2016 Results
9th Nov 2016 7:00 am RNS Directorate Change
1st Nov 2016 3:30 pm RNS Dealing by Person Closely Associated
1st Nov 2016 3:00 pm RNS Total Voting Rights
31st Oct 2016 1:47 pm RNS AZ completes US Aralez agreement for Toprol-XL
27th Oct 2016 4:51 pm RNS AstraZeneca Head and Neck Cancer Trials
26th Oct 2016 7:00 am RNS Positive results in AstraZeneca Lynparza trial
18th Oct 2016 7:00 am RNS FDA accepts for review ZS-9 NDA for hyperkalaemia
7th Oct 2016 7:00 am RNS AZ DIVESTS RIGHTS TO RHINOCORT AQUA OUTSIDE US
4th Oct 2016 7:05 am RNS AZ agreement with Aralez for Toprol-XL in US
4th Oct 2016 7:00 am RNS AstraZeneca reports top-line EUCLID results in PAD
3rd Oct 2016 3:00 pm RNS Total Voting Rights
3rd Oct 2016 7:00 am RNS MedImmune out-licenses medicine to Allergan
28th Sep 2016 7:00 am RNS CHANGE TO ASTRAZENECA BOARD OF DIRECTORS
26th Sep 2016 4:00 pm RNS Director/PDMR Shareholding
22nd Sep 2016 11:00 am RNS Director Declaration
1st Sep 2016 2:30 pm RNS Total Voting Rights
1st Sep 2016 7:00 am RNS AstraZeneca Completes Aspen Agreement
24th Aug 2016 7:00 am RNS AZ TO SELL ANTIBIOTICS BUSINESS TO PFIZER
18th Aug 2016 1:00 pm RNS Director Declaration
16th Aug 2016 7:00 am RNS AstraZeneca completes agreement with LEO Pharma
10th Aug 2016 2:41 pm RNS ASTRAZENECA ANNOUNCES INVESTMENT IN MODERNA
9th Aug 2016 7:00 am RNS ASTRAZENECA UPDATE ON SELUMETINIB PHASE III TRIAL
1st Aug 2016 2:30 pm RNS Total Voting Rights
1st Aug 2016 11:00 am RNS Director/PDMR Shareholding
28th Jul 2016 7:00 am RNS AZN: H1 2016 Results
27th Jul 2016 9:00 am RNS Notice of Results
19th Jul 2016 2:15 pm RNS QTERN (saxa/dapa) EU approved for type-2 diabetes
18th Jul 2016 7:00 am RNS TAGRISSO MET PRIMARY ENDPOINT IN PHASE III TRIAL
14th Jul 2016 12:07 pm RNS Second Price Monitoring Extn
14th Jul 2016 12:02 pm RNS Price Monitoring Extension
13th Jul 2016 7:00 am RNS AZ resolves Faslodex patent litigation in the US
1st Jul 2016 5:30 pm RNS Total Voting Rights
28th Jun 2016 7:00 am RNS Zavicefta approved in EU
23rd Jun 2016 7:00 am RNS AstraZeneca updates on Flumist vaccine in the US
14th Jun 2016 3:00 pm RNS Director/PDMR Shareholding
9th Jun 2016 7:03 am RNS AZ agreement with Aspen for anaesthetics portfolio
3rd Jun 2016 7:00 am RNS AZ completes US licensing agreement with Ironwood
2nd Jun 2016 7:00 am RNS AZ LICENSES ZURAMPIC TO GRÜNENTHAL GMBH
1st Jun 2016 12:00 pm RNS Block listing Interim Review
FTSE 100 Latest
Value8,837.91
Change26.87